BioLingus AG Information

BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of products for treatment of metabolic diseases and various immuno-therapies.

Website	http://biolingus.ch
Revenue	$5.1 million
Employees	5 (0 on RocketReach)
Founded	2014
Address	6 Grossmatt, Hergiswil, Nidwalden 6052, CH
Phone	+41 78 664 54 30
Industry	Pharmaceutical Manufacturing, Business Services General, Biometrics, Business Services, Biotechnology, Data and Analytics, Science and Engineering, Medical Device, Health Care, Pharmaceutical, Therapeutics
Keywords	Biotechnology, Peptide Delivery, Protein Delivery, Drug Delivery, Pharmaceutical Formulation, Chronic Disease Treatment, Immunotherapy, Biopharma, Therapeutic Peptides, Therapeutic Proteins, Peptide Therapeutics, Protein Therapeutics, Drug Development, Pharmaceutical Research, Biotech Research, Oral Drug Delivery
Competitors	Genomatix AG, Geneious, Thermo Fisher Scientific, Illumina, Boehringer Ingelheim, Eurofins, Roche, QIAGEN, Novartis, Agilent Technologies +35 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies